Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

2(40.0%)

Phase 4

2(40.0%)

Phase 3

1(20.0%)

5Total

Phase 2(2)

Phase 4(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT03228992Phase 4Completed

Ibuprofen Versus Placebo For Muscle Soreness

Role: lead

NCT02541396Phase 2Completed

A Study Of The Effectiveness Of Wafermine Alone And In Combination With Opioids In Subjects Undergoing Bunionectomy

Role: collaborator

NCT02113566Phase 4Completed

A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness

Role: lead

NCT02356965Phase 2Completed

Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction

Role: collaborator

NCT00707057Phase 3Completed

Ibuprofen Extended-Release Dental Pain Study

Role: collaborator

All 5 trials loaded